Evidence map›Paper›PMID 32206251›Full record

ArticleChemical science2019

Blue thermally activated delayed fluorescence emitters incorporating acridan analogues with heavy group 14 elements for high-efficiency doped and non-doped OLEDs.

Kyohei Matsuo, Takuma Yasuda

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kyohei MatsuoINAMORI Frontier Research Center (IFRC) , Kyushu University , 744 Motooka, Nishi-ku , Fukuoka 819-0395 , Japan . Email: yasuda@ifrc.kyushu-u.ac.jp.ORCID 0000-0002-2472-9459
Takuma YasudaINAMORI Frontier Research Center (IFRC) , Kyushu University , 744 Motooka, Nishi-ku , Fukuoka 819-0395 , Japan . Email: yasuda@ifrc.kyushu-u.ac.jp.ORCID 0000-0003-1586-4701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep-blue thermally activated delayed fluorescence (TADF) emitters are promising alternatives for conventional fluorescence and phosphorescence materials for practical application in organic light-emitting diodes (OLEDs). However, as appropriate bipolar hosts for deep-blue TADF-OLEDs are scarce, the development of efficient deep-blue TADF emitters that are applicable to both doped and non-doped systems is an urgent task. In this study, we developed a new family of blue TADF emitters that demonstrated high photoluminescence (PL) and electroluminescence (EL) quantum efficiencies in both doped and non-doped (neat) systems. Four new donor-acceptor (D-A)-type TADF molecules incorporating phenazasiline, phenazagermine, and tetramethylcarbazole as weak D units and phenothiaborin as a weak A unit were designed and synthesized. By varying the structural rigidity/flexibility as well as the electron-donating ability of the D units, the resulting photophysical and TADF properties of the D-A molecules could be systematically regulated. A comprehensive photophysical investigation revealed that phenazasiline and phenazagermine-based emitters concurrently exhibit blue TADF emissions (464-483 nm), high PL quantum efficiencies (∼100%), extremely fast spin-converting reverse intersystem crossing rates (>10

Identifiers

PMID32206251
PMCPMC7069243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.